Biografia del Dr. Lanfranco Pellesi

Dr. Lanfranco PellesiDr. Lanfranco Pellesi – Nato il 08/04/1989 a Modena (MO).

 

Istruzione e formazione

  • 5 marzo 2015 – Laurea magistrale in Medicina e Chirurgia, Università di Modena e Reggio Emilia.
  • 31 ottobre 2019 – Specialista medico in farmacologia e tossicologia clinica presso l´Università degli Studi di Firenze.

Esperienze lavorative

  • 17 gennaio 2019 ad oggi – Assistente Ricercatore e PhD student presso il Danish Headache Center, Copenhagen (Danimarca)
  • 1 novembre 2015 al 16 gennaio 2019 – Medico in formazione specialistica presso il Centro Cefalee ed Abuso di Farmaci dell´Università di Modena e Reggio Emilia (Italia).

 

Membro delle seguenti società e associazioni:
o Associazione internazionale per lo studio del dolore (IASP)
o International Headache Society (IHS)
o Società Italiana di Farmacologia (SIF)
o Società Italiana per lo studio del mal di testa (SISC)

 

Pubblicazioni scientifiche

  • Pellesi L, Cevoli S, Favoni V, Lupi C, Mampreso E, Negro A, Russo A, Benemei S, Guerzoni S (2019).
    Nummular headache: a gender-oriented perspective on a case series from the RegistRare network.
    Neurol Sci 2019 Nov 13; Online ahead of print.
  • Pellesi L, Bellei E, Guerzoni S, Cainazzo MM, Baraldi C, Monari E, Pini LA (2019). Exploration of
    candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse
    headache. BMC Neurol, 19(1): 239.
  • Pellesi L, Verga MC, De Maria N, Villa E, Pini LA, Guerzoni S (2019). Nabilone administration in
    refractory chronic diarrhea: a case series. BMC Gastroenterol, 19 (1): 105.
  • Lupi C, Benemei S, Guerzoni S, Pellesi L, Negro L (2019). Pharmacokinetics and pharmacodynamics of
    new acute treatments for migraine. Expert Opinion on Drug Metabolism and Toxicology, 15 (3): 189-
    198.
  • Sacco S, Benemei S, Cevoli S, Coppola G, Cortelli P, De Cesaris F, De Icco R, De Marco CM, Di Lorenzo C, Geppetti P, Manni A, Negro A, Ornello R, Pierangeli G, Pierelli F, Pellesi L, Pini LA, Pistoia F, Prudenzano MP, Russo A, Sances G, Taranta V, Tassorelli C, Tedeschi G, Trojano M, Martelletti P (2019). Development and validation of the ID-EC – the ITALIAN version of the identify chronic migraine. J Headache Pain, 20 (1): 15.
  • Pellesi L, Licata M, Verri P, Vandelli D, Palazzoli F, Marchesi F, Cainazzo MM, Pini LA, Guerzoni S (2018).
    Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse
    headache (MOH) – a pilot study. Eur J Clin Pharmacol, 74 (11): 1427-1436.
  • Vollesen AL, Benemei S, Cortese F, Labastida-Ramìrez A, Marchese F, Pellesi L, Romoli M, Ashina M,
    Lampl C, on behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)
    (2018). Migraine and cluster headache – the common link. J Headache Pain; 19: 89.
  • Di Lorenzo C, Pellesi L, Coppola G, Parisi V, Evangelista M, Guerzoni S, Rossi P, Serrao M, Pini LA, Pierelli
    F (2018). Efficacy of transdermal rotigotine in chronic cluster headache: a case series. Cephalalgia
    Reports, https://doi.org/10.1177/2515816318809697.
  • Guerzoni S, Pellesi L, Pini LA, Caputo F (2018). Response to: "Drugs for treatment for alcohol use
    disorders expose to interactions with others … for little benefit if any". Pharmacol Res, 134: 220.
  • Guerzoni S, Pellesi L, Pini LA, Caputo F (2018). Drug-drug interactions in the treatment for alcohol use
    disorders: a comprehensive review. Pharmacol Res, 133: 65-76.
  • Guerzoni S, Pellesi L, Baraldi C, Cainazzo MM, Negro A, Martelletti P, Pini LA. Supplementary
    Addendum to “Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in
    Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy”.
    Front Neurol, 9: 641.
  • Lupi C, Evangelista L, Favoni V, Granato A, Negro A, Pellesi L, Ornello R, Russo A, Cevoli S, Guerzoni S,
    Benemei S (2018). Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide
    retrospective data from the RegistRare Network. Cephalalgia, 38 (8): 1429-1441.
  • Baraldi C, Pellesi L, Guerzoni S, Cainazzo MM, Pini LA (2017). Therapeutical approaches to paroxysmal
    hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical
    appraisal. J Headache Pain, 18 (1): 71.
  • Guerzoni S, Pellesi L, Baraldi C, Cainazzo MM, Negro A, Martelletti P, Pini LA (2017). Long term
    treatment benefits and prolonged efficacy of OnabotulinumtoxinA in patients affected by chronic
    migraine and medication overuse headache over three years of therapy. Front Neurol, 8: 586.
  • Pellesi L, Benemei S, Favoni V, Lupi C, Mampreso E, Negro A, Paolucci M, Steiner TJ, Ulivi M, Cevoli S,
    Guerzoni S (2017). Quality indicators in headache care: an implementation study in six Italian specialist-
    care centres. J Headache Pain, 18 (1): 55.
  • Benemei S, Cortese F, Labastida-Ramírez A, Marchese F, Pellesi L, Romoli M, Vollesen AL, Lampl C,
    Ashina M, on behalf of the School of Advanced Studies of the European Headache Federation (EHF-
    SAS) (2017). Triptans and CGRP blockade – impact on the cranial vasculature. J Headache Pain, 18 (1):
    103.
  • Pellesi L, Guerzoni S, Pini LA (2017). Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The
    Clinical Evidence to Date. Clin Pharmacol Drug Dev, 6 (6): 534-547.
  • Baraldi L, Licata M, Palazzoli F, Marchesi F, Pellesi L, Raffaelli G, Ferrari A (2016). Diagnostic accuracy of
    hair analysis for the detection of triptan overuse in migraineurs. Toxicology Letters, 258: S102.
  • Guerzoni S, Pellesi L, Baraldi C, Pini LA (2015). Increased efficacy of regularly repeated cycles with
    OnabotulinumtoxinA in MOH patients beyond the first year of treatment. J Headache Pain; 17: 48.

 

Collaborazione alla scrittua di libri

  • Cainazzo MM, Pellesi L (2017). Trattamento di una giovane emicranica in etá pediatrica. In: Menthalia
    (Eds.), L´uso degli integratori nel trattamento delle cefalee.
  • Guerzoni S, Baraldi C, Pellesi L, Pini LA (2016). Cefalea e cannabinoidi. In: Migra Lab (Eds.), Approccio
    clinico alle cefalee.

 

Posters e presentazioni

  • Magnani L, Lumetti F, Cocchiara E, Spinella A, Baraldi C, Pini LA, Pellesi L, Baiocchi G, Salvarani C,
    Giuggioli D. Evaluation of chronic pain in patients with systemic sclerosis compared to those with
    chronic headache and rheumatoid arthritis. Annals of the Rheumatic Diseases 2019; 78 (Suppl 2):
    1219.2-1220.
  • Pellesi L, Bellei E, Baraldi C, Cainazzo MM, Guerzoni S, Monari E, Pini LA. Serum changes of
    apolipoproteins in Medication Overuse Headache (MOH). Poster presented at 12th European
    Headache Federation Congress, September 2018, Florence (Italy).
  • Pellesi L, Benemei S, Cevoli S, Favoni V, Lupi C, Mampreso E, Russo A, Guerzoni S. Clinical report of
    nineteen Italian patients with nummular headache. Oral presentation presented at 32nd National
    Congress of the Italian Society for the Study of Headaches, September 2018, Florence (Italy).
  • Pellesi L. Exploration of potential serum candidates biomarkers in Medication Overuse Headache. Oral
    presentation presented at “iHead – a development program of the International Headache Society”, 3
    September 2018, London.
  • Pellesi L, Guerzoni S, Licata M, Pini LA. Proprietà farmacocinetiche di cannabis FM2 assunta per via
    orale in pazienti con Medication Overuse Headache (MOH). Oral presentation presented at “New and
    old challenges for clinical pharmacology: from therapeutic drug monitoring to pharmacogenetics and
    pharmacovigilance”, Naples (Italy), March 2018.
  • Pellesi L. Pharmacokinetics and tolerability of oral cannabis preparations in chronic headache patients.
    Oral presentation presented at “New therapeutic strategies for chronic pain: from Botulinum Toxin to
    medical cannabis”, Modena (Italy), January 2018.
  • Pellesi L, Guerzoni S, Licata M, Pini LA. Clinical pharmacokinetics of oral cannabis FM2 preparations in
    Medication Overuse Headache (MOH) patients. Oral presentation presented at 9th National Congress
    of Italian Society of Drug Addiction (SITD).
  • Cainazzo MM, Bacchelli E, Baraldi C, Guerzoni S, Pellesi L, Zoli M, Maestrini E, Pini LA. Clinical
    evaluation in two sub-population of cluster headache patients with neprilysin (NEP) and pituitary
    adenyl cyclase activating polypeptide (PACAP) receptor gene variants. Poster presented at 31th
    National Congress of SISC, Rome (Italy).
  • Pellesi L, Guerzoni S, Licata M, Pini LA. Clinical pharmacokinetics of oral cannabis FM2 preparations in
    Medication Overuse Headache (MOH) patients. Poster presented at 31th National Congress of SISC,
    Rome (Italy).
  • Pellesi L, Guerzoni S, Baraldi C, Cainazzo MM, Pini LA. Adherence to prophylaxis pharmacotherapies in
    patients with medication overuse headache: a 10-year experience in a single centre. Poster presented
    at 11th European Headache Federation Congress, Rome (Italy).
  • Evangelista L, Guerzoni S, Pellesi L, Pistoia F, Tiseo C, Pini LA, Sacco S. The profile of super responders
    to Onabotulinumtoxin A for chronic migraine: data from an observational study. Poster presented at
    11th European Headache Federation Congress, Rome (Italy).
  • Pellesi L, Benemei S, Favoni V, Lupi C, Mampreso E, Negro A, Paolucci M, Steiner TJ, Ulivi M, Cevoli S,
    Guerzoni S. Quality indicators in headache care: an implementation study in six Italian specialist-care
    centres. Poster presented at 18th Congress of the International Headache Society, Vancouver (Canada).
  • Pellesi L, Baraldi C, Favoni V, Lupi C, Mampreso E, Paolucci M, Negro A, et al. Quality indicators in
    headache care: a multicentre implementation study in seven italian specialist-care centres. Oral
    presentation at 2nd National Congress ANIRCEF-SISC, Bologne (Italy).
  • Guerzoni S, Pellesi L, Baraldi C, Cainazzo MM, Pini LA. Use of transdermal rotigotine as prophylactic
    treatment in refractory chronic headaches: a case series. Poster presented at 2nd National Congress
    ANIRCEF-SISC, Bologne (Italy).
  • Pellesi L. Righetti A, Baraldi C, Mori F, Guerzoni S, Pini LA, Brugioni L. Asymmetry of internal jugular
    vein and its relationship with chronic migraine. Poster presented at 2nd National Congress ANIRCEF-
    SISC, Bologne (Italy).

RESTA AGGIORNATO

 

Iscriviti alla newsletter per ricevere le ultime news


Fisioterapia Rubiera